Drug Type Chemical drugs |
Synonyms + [3] |
Target |
Mechanism AMPA receptor antagonists(Glutamate receptor ionotropic AMPA antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Proniras Corp.Startup |
Active Organization Proniras Corp.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Central Nervous System Diseases | Preclinical | CN | Proniras Corp.Startup | 24 May 2024 |